NEW YORK (GenomeWeb) – BGI said today that is has launched the George Church Institute of Regenesis, which plans to focus on synthetic biology technologies and applications, and will collaborate with Church, a professor of genetics at Harvard Medical School.

Church, a longtime advisor to BGI, will be chief scientist of the institute that bears his name, which is co-located with the China National GeneBank in Shenzhen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.